Clinical Trials Browser

Unspecified Adult Solid Tumor, Protocol Specific

NCT01573780 2022-08-15

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

Phase 1 Terminated

21 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00008125 2016-01-15

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

25 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00217477 2014-12-09

Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer

Phase 1 Completed

34 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004144 2014-04-24

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00054288 2014-01-13

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005996 2013-12-19

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00243100 2013-12-16

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

21 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00020644 2013-08-07

Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer

Phase 1 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004090 2013-07-10

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00072228 2013-07-10

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00072436 2013-07-02

Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

Phase 1 Completed

58 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00047047 2013-06-04

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

78 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00021346 2013-04-17

Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

8 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003925 2013-04-08

Combination Chemotherapy In Treating Patients With Advanced Cancer

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00007917 2013-02-28

Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

58 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004242 2013-02-11

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00079352 2013-01-25

Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

24 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00078962 2013-01-24

GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003707 2012-06-28

Combination Chemotherapy in Treating Patients With Advanced Cancer

Phase 1 Completed

22 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00307255 2012-04-04

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors

Phase 1 Completed

18 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00459836 2011-03-02

PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors

Phase 1 Completed

42 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006372 2010-06-11

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

10 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004220 2010-01-13

Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004063 2009-04-30

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

Phase 1/2 Unknown

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00043095 2008-07-24

BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00274859 2008-07-24

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer

Phase 2 Unknown

45 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy In Treating Patients With Advanced Cancer

Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Cancer

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors

PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer